Join our speakers as they discuss their time in the Pharmaceuticals & Life Sciences industries. Hear about their educations and backgrounds, what made them choose a career in the space, tips for students and those considering a transition, and more! Bring your questions to this interactive session, or submit them in advance during registration.
Do you feel confident in your understanding of Artificial Intelligence in the Healthcare Industry? Are you interested in learning about how AI is currently used and future trends in hospital systems, payers, pharma, CROs and other healthcare organizations? If so, join our guest experts to demystify AI and help you confidently employ this game changing technology now and in in your future roles. This discussion is designed to equip MBAs, graduate students, and professionals with a basic understanding of AI and its applications within the healthcare industry. Our experts will unravel the intricacies of AI technologies, and explore their transformative impact on healthcare delivery, patient outcomes, and business operations. Gain valuable insights into real case uses where AI is currently being applied and the hopes for future applications. Whether you aspire to lead healthcare organizations or drive innovation in the industry, this panel offers invaluable perspectives to help you leverage AI knowledge effectively and navigate the evolving landscape of healthcare business with confidence and expertise. Bring your burning questions and plan to join this fascinating and valuable discussion.
Join us for a captivating Fireside Chat with Minni Marwaha, the dynamic Founder of Deebo, an at home medical tool for parents. Minni’s mission is to empower parents by providing them with easy-to-use medical devices to take health matters into their own hands, right in the comfort of their homes. Discover how she’s making a positive impact on healthcare! With a remarkable background that includes leading Core Innovation for Advocate Aurora Healthcare, one of the largest healthcare systems in the US, Minni is a powerhouse of knowledge and experience.
India’s drug regulator authorized the country’s first nasal spray vaccine on Tuesday, marking a big step toward increasing the availability of newly popular needle-free vaccines around the world.
Due to drug overdoses and COVID-19 deaths, life expectancy in the U.S. has dropped for the second straight year.
California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.
Editas Medicine has confirmed that a cell therapy for sickle cell disease has successfully engrafted into the first patient dosed in a phase 1/2 trial, which means—for those of us without a science degree—the therapy has been accepted by the patient's body and is starting to create new blood cells as planned.
New medical innovations provides glimmer of hope for the development of complex kidney organoids that can be used as a substitute for kidney transplants.
The Coalition for Epidemic Preparedness Innovations will provide funding up to $375,000 to support the development of laboratory tools to assess monkeypox vaccines.
Use of computational software in drug research is growing, and some big tech companies are angling for a piece of this market. Cadence Design Systems is entering the life sciences sector through the $500 million acquisition of OpenEye Scientific, a company that provides computational drug design software to the pharmaceutical industry.
Pharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.
The bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line.